We observed that among tested cell lines, K-562, a Philadelphia (Ph) chromosome-positive (BCR-ABL-positive) leukemia cell line derived from chronic myeloid leukemia (CML) in blast crisis [53], was the most resistant toward the tested compounds. The gene discussed is ABL1; the disease is leukemia.